Effects of supervised structured aerobic exercise training (SSAET) on patients with type 2 diabetes mellitus compared with routine medical management

Effects of supervised structured aerobic exercise training (SSAET) on patients with type 2 diabetes mellitus compared with routine medical management: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16466697

Enrollment

100

Registered

2016-12-12

Start date

2015-01-01

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 2 Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

1. The control group received routine medication and dietary plan (non-exercised group) 2. The experimental group received the SSAET program, routine medication and dietary plan (exerc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes mellitus diagnosed as per WHO criteria 2. Established diagnosis of type 2 diabetes mellitus with 1 year history 3. Age 30-70 4. No other post-diabetic complications or comorbidity 5. No prior history of regular physical exercise

Exclusion criteria

Exclusion criteria: 1. Patients with type 1 diabetes mellitus or pregnancy induced diabetes 2. Aged less than 30/more than 70 3. Patients with any other post-diabetic complications or comorbidity 4. Musculoskeletal, cardiopulmonary or neurological problems. 5. Smokers 6. Patients with type 2 diabetes mellitus with a history of regular exercise

Design outcomes

Primary

Measure	Time frame
1. Insulin resistance, measured using the HOMA Method 2. Glycemic control (HbA1c), measured using a kit 3. Plasma insulin level, measured using a kit 4. Fasting blood glucose level, estimated by glucometer Measured at baseline and at the completion of 6 month (25 weeks) intervention.	—

Secondary

Measure	Time frame
1. LDL and HDL cholesterol, measured from blood by using kits 2. Aerobic capacity (VO2 peak), measured by resting heart rate based method 3. Body weight 4. Body mass index (BMI) 5. Level of exertion, measured using the Borge scale 6. Dyspnea, measured by dyspnea index 7. Blood pressure, measured by BP apparatus 8. Post diabetic complications, measured by physical examination 9. Inflammatory markers, measured by Human ELISA Kits Measured at baseline and at the completion of 6 month (25 weeks) intervention.	—

Measure

Time frame

1. LDL and HDL cholesterol, measured from blood by using kits 2. Aerobic capacity (VO2 peak), measured by resting heart rate based method 3. Body weight 4. Body mass index (BMI) 5. Level of exertion, measured using the Borge scale 6. Dyspnea, measured by dyspnea index 7. Blood pressure, measured by BP apparatus 8. Post diabetic complications, measured by physical examination 9. Inflammatory markers, measured by Human ELISA Kits Measured at baseline and at the completion of 6 month (25 weeks) intervention.

—

Countries

Pakistan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026